Serum Copper Level and Its Relation with Blood Pressure and Urinary Protein Level in Preeclampsia

S H Lisa1, Q S Akhter, A Nessa

  • 1Dr Saima Haque Lisa, Assistant Professor, Department of Physiology, Parkview Medical College, Sylhet, Bangladesh;

Insights

Serum copper levels are significantly higher in preeclampsia patients. Elevated copper is positively linked to increased blood pressure and urinary protein, suggesting its potential role in predicting preeclampsia risk.

Area of Science:

  • Obstetrics and Gynecology
  • Clinical Chemistry
  • Trace Element Research

Background:

  • Preeclampsia is a complex pregnancy disorder linked to oxidative stress.
  • Alterations in essential trace elements may influence preeclampsia development.

Purpose of the Study:

  • To evaluate serum copper (Cu) levels in preeclampsia patients.
  • To investigate the relationship between serum copper and blood pressure/urinary protein.

Main Methods:

  • Cross-sectional study comparing 30 preeclampsia patients with 30 healthy pregnant controls.
  • Serum copper levels measured using established laboratory methods.
  • Statistical analysis included unpaired Student's t-test and Pearson's correlation coefficient.

Main Results:

  • Serum copper levels were significantly higher (p<0.001) in preeclampsia patients compared to controls.
  • Serum copper showed positive correlations with systolic and diastolic blood pressure.
  • A positive correlation was observed between serum copper and urinary protein levels.

Conclusions:

  • Serum copper levels are elevated in preeclampsia and positively correlate with disease severity markers.
  • Early pregnancy serum copper estimation may aid in predicting preeclampsia risk.

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
178
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
34.8K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
57
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
313
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
175
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K